#United States #New York #PK Consumer Health #HealthAid #VMS Products

PK Consumer Health's Strategic Acquisition of HealthAid

In a significant move to expand its influence in the healthcare market, PK Consumer Health, a subsidiary of Avista Healthcare Partners and Damier Group, has announced the acquisition of HealthAid Limited and HealthAid America Inc. This transaction marks the second acquisition for PK since Avista and Damier's investment in late 2025, aimed at solidifying PK’s status as a leading “retail-first” player in the Vitamins, Minerals, and Supplements (VMS) sector.

Overview of HealthAid

HealthAid, headquartered in Harrow, UK, has established itself as a trusted name in the VMS sector, supplying high-quality products to thousands of independent pharmacies around the globe. Their offerings cover an extensive range of categories and formats, catering to diverse consumer needs. Currently, HealthAid operates in over 50 countries, highlighting its extensive global distribution network built through long-term partnerships, some lasting over three decades.

The acquisition aligns with PK Consumer Health's vision of uniting successful local brands across Europe, positioning them to achieve their ambitious revenue growth projections, which now approach EUR 200 million. This strategic integration not only enhances PK’s market reach but also supports its ongoing efforts to bolster its management structure and implement synergies across its portfolio.

Leadership Insights

Yvan Vindevogel, Chairman of PK Consumer Health, expressed enthusiasm about welcoming HealthAid into the PK family. He acknowledged the collaborative potential this merger presents, emphasizing the advantages of leveraging PK's extensive capabilities alongside HealthAid's esteemed market reputation. According to Vindevogel, this acquisition is a crucial move toward realizing PK's goal of achieving EUR 100 million in EBITDA.

The transaction, slated to finalize in March 2026, underscores PK's commitment to continuous improvement and expansion in the consumer health sector. Financial specifics of the deal have not been disclosed, but the strategic advisory roles played by Eight Advisory, OCC, and Ropes & Gray indicate the high stakes of this venture.

Future Prospects

The acquisition of HealthAid signifies a pivotal moment for PK Consumer Health as it continues its trajectory toward becoming a dominant player in the retail-oriented VMS market. Moving forward, PK is poised to actively seek additional merger and acquisition opportunities across Europe, enhancing its brand portfolio and driving sustainable growth.

HealthAid’s dedication to providing superior service and a diverse range of quality VMS products makes it a valuable addition to PK's offerings, ensuring pharmacies can meet their customers' health needs effectively. This merger is not only about growth in revenue; it's about the commitment to improving consumer health outcomes through accessible, high-quality health products.

In summary, PK Consumer Health’s acquisition of HealthAid is set to propel both companies toward a new chapter of growth and partnership, emphasizing a shared vision for excellence in consumer healthcare.